Tags

Type your tag names separated by a space and hit enter

Molecular Targets for the Testing of COVID-19.
Biotechnol J. 2020 Jun; 15(6):e2000152.BJ

Abstract

The pandemic outbreaks of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread all over the world in a short period of time. Efficient identification of the infection by SARS-CoV-2 has been one of the most important tasks to facilitate all the following counter measurements in dealing with the infectious disease. In Taiwan, a COVID-19 Open Science Platform adheres to the spirit of open science: sharing sources, data, and methods to promote progress in academic research while corroborating findings from various disciplines has established in mid-February 2020, for collaborative research in support of the development of detection methods, therapeutics, and a vaccine for COVID-19. Research priorities include infection control, epidemiology, clinical characterization and management, detection methods (including viral RNA detection, viral antigen detection, and serum antibody detection), therapeutics (neutralizing antibody and small molecule drugs), vaccines, and SARS-CoV-2 pathogenesis. In addition, research on social ethics and the law are included to take full account of the impact of the COVID-19 virus.

Authors+Show Affiliations

Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, 300, Taiwan.Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, 300, Taiwan.Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, 300, Taiwan.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32419272

Citation

Yong, Suh Kuan, et al. "Molecular Targets for the Testing of COVID-19." Biotechnology Journal, vol. 15, no. 6, 2020, pp. e2000152.
Yong SK, Su PC, Yang YS. Molecular Targets for the Testing of COVID-19. Biotechnol J. 2020;15(6):e2000152.
Yong, S. K., Su, P. C., & Yang, Y. S. (2020). Molecular Targets for the Testing of COVID-19. Biotechnology Journal, 15(6), e2000152. https://doi.org/10.1002/biot.202000152
Yong SK, Su PC, Yang YS. Molecular Targets for the Testing of COVID-19. Biotechnol J. 2020;15(6):e2000152. PubMed PMID: 32419272.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Molecular Targets for the Testing of COVID-19. AU - Yong,Suh Kuan, AU - Su,Ping-Chia, AU - Yang,Yuh-Shyong, Y1 - 2020/05/18/ PY - 2020/03/30/received PY - 2020/04/14/revised PY - 2020/5/19/pubmed PY - 2020/6/17/medline PY - 2020/5/19/entrez KW - COVID-19 KW - SARS-CoV-2 KW - coronavirus KW - molecular testing KW - rapid-diagnostic test (RDT) KW - serology testing SP - e2000152 EP - e2000152 JF - Biotechnology journal JO - Biotechnol J VL - 15 IS - 6 N2 - The pandemic outbreaks of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread all over the world in a short period of time. Efficient identification of the infection by SARS-CoV-2 has been one of the most important tasks to facilitate all the following counter measurements in dealing with the infectious disease. In Taiwan, a COVID-19 Open Science Platform adheres to the spirit of open science: sharing sources, data, and methods to promote progress in academic research while corroborating findings from various disciplines has established in mid-February 2020, for collaborative research in support of the development of detection methods, therapeutics, and a vaccine for COVID-19. Research priorities include infection control, epidemiology, clinical characterization and management, detection methods (including viral RNA detection, viral antigen detection, and serum antibody detection), therapeutics (neutralizing antibody and small molecule drugs), vaccines, and SARS-CoV-2 pathogenesis. In addition, research on social ethics and the law are included to take full account of the impact of the COVID-19 virus. SN - 1860-7314 UR - https://www.unboundmedicine.com/medline/citation/32419272/Molecular_Targets_for_the_Testing_of_COVID_19_ L2 - https://doi.org/10.1002/biot.202000152 DB - PRIME DP - Unbound Medicine ER -